Cargando…
Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model
Background and Aim. Crohn's disease is associated with gut microbiota (GM) dysbiosis. Treatment with the anti-IL-12p40 monoclonal antibody (12p40-mAb) has therapeutic effect in Crohn's disease patients. This study addresses whether a 12p40-mAb treatment influences gut microbiota (GM) compo...
Autores principales: | Castro-Mejía, Josué, Jakesevic, Maja, Krych, Łukasz, Nielsen, Dennis S., Hansen, Lars H., Sondergaard, Bodil C., Kvist, Peter H., Hansen, Axel K., Holm, Thomas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736578/ https://www.ncbi.nlm.nih.gov/pubmed/26880890 http://dx.doi.org/10.1155/2016/4953120 |
Ejemplares similares
-
Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease
por: Holm, Thomas Lindebo, et al.
Publicado: (2018) -
Quantitatively Different, yet Qualitatively Alike: A Meta-Analysis of the Mouse Core Gut Microbiome with a View towards the Human Gut Microbiome
por: Krych, Lukasz, et al.
Publicado: (2013) -
Controlling the uncontrolled variation in the diet induced obese mouse by microbiomic characterization
por: Bondarenko, Valeriia, et al.
Publicado: (2022) -
Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination
por: Kihl, Pernille, et al.
Publicado: (2022) -
Mouse Vendor Influence on the Bacterial and Viral Gut Composition Exceeds the Effect of Diet
por: Rasmussen, Torben Sølbeck, et al.
Publicado: (2019)